|drug639||COVID-19 PCR Swab Wiki||1.00|
|drug3705||Wearable Medical Device (Empatica E4) Wiki||1.00|
|D002659||Child Development Disorders, Pervasive NIH||0.45|
|D001321||Autistic Disorder NIH||0.33|
|D000067877||Autism Spectrum Disorder NIH||0.30|
There is one clinical trial.
This is a prospective observational cohort study of healthcare workers working in high-risk COVID-19 clinical areas, monitoring heart rate, sleep and temperature, correlating with daily self-reported symptoms, oxygen saturations and PCR Swabs. It will provide information about how many healthcare workers develop COVID-19, what their clinical observations and symptoms are.
Description: Number of Healthcare Workers who have a new PCR positive diagnosis of COVID-19Measure: COVID-19 Infection Time: 30 days
Description: What new symptoms healthcare workers develop when they develop COVID-19 infectionMeasure: Symptoms Time: 30 days
Description: What healthcare workers observations are when they develop COVID-19 infection including: Oxygen saturations, Heart Rate, Skin TemperatureMeasure: Clinical Observations Time: 30 days
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.Drug Reports MeSH Reports HPO Reports